PIRAMAL PHARMA
|
The Current P/S Ratio of PIRAMAL PHARMA is 2.96.
Share Price | ₹203.2 | Sep 17,2025 |
Market Cap | ₹27,002.7 Cr | |
Sales-TTM | ₹9,133.8 Cr | TTM-Consolidated Results |
Price/Sales | 2.96x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of PIRAMAL PHARMA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹27,002.7 Cr] as on Sep 17,2025
(/) Sales [ ₹9,133.8 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 2.96x ]
Thus, for PIRAMAL PHARMA , the investors are currently willing to pay '2.96 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of PIRAMAL PHARMA !
The chart below summarizes the trend in P/S Ratio of PIRAMAL PHARMA over the last five years.
Historical PS (Price/Sales) ratio chart of PIRAMAL PHARMA
PS Ratio Performance Analysis for PIRAMAL PHARMA
- PIRAMAL PHARMA 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 1.30x.
- PIRAMAL PHARMA 's operated at median p/e ratio of 1.15x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, PIRAMAL PHARMA 's p/e ratio peaked in Mar2025 at 3.25x.
- PIRAMAL PHARMA 's p/e ratio hit its five-year low in Mar2022 of 0x.
How does PIRAMAL PHARMA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
PIRAMAL PHARMA | 9,133.8 | 2.96 | 27,002.7 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 53,777.1 | 7.23 | 388,752.0 |
DIVIS LABORATORIES LTD | 9,652.0 | 16.64 | 160,626.0 |
CIPLA LTD | 27,811.2 | 4.53 | 125,951.0 |
TORRENT PHARMACEUTICALS LTD | 11,835.0 | 10.13 | 119,932.0 |
DR REDDYS LABORATORIES LTD | 33,519.9 | 3.26 | 109,414.0 |
MANKIND PHARMA LTD | 12,956.2 | 8.18 | 106,025.0 |
ZYDUS LIFESCIENCES LTD | 23,607.7 | 4.41 | 104,130.0 |
LUPIN LTD | 23,375.9 | 3.97 | 92,773.7 |
AUROBINDO PHARMA LTD | 32,024.8 | 1.99 | 63,670.4 |
ABBOTT INDIA LTD | 6,589.9 | 9.98 | 65,762.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs PIRAMAL PHARMA 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 1.99x |
Max industry PS | 16.64x |
Median industry PS | 4.53x |
Average industry PS | 6.66x |
You may also like the below Video Courses